Intermittent Theta Burst Stimulation Attenuates Cognitive Deficits and Alzheimer’s Disease-Type Pathologies via ISCA1-Mediated Mitochondrial Modulation in APP/PS1 Mice-Reference-Cited by-同舟云学术

Intermittent Theta Burst Stimulation Attenuates Cognitive Deficits and Alzheimer’s Disease-Type Pathologies via ISCA1-Mediated Mitochondrial Modulation in APP/PS1 Mice

Published:2023-08-14 Issue:2 Volume:40 Page:182-200
ISSN:1673-7067
Container-title:Neuroscience Bulletin
language:en
Short-container-title:Neurosci. Bull.

Author:

Zhu Yang,Huang Hao,Chen Zhi,Tao Yong,Liao Ling-Yi,Gao Shi-Hao,Wang Yan-Jiang,Gao Chang-Yue^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Physiology,General Neuroscience

Link

https://link.springer.com/content/pdf/10.1007/s12264-023-01098-7.pdf

Reference65 articles.

1. Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE. Alzheimer’s disease. Lancet 2021, 397: 1577–1590.

2. Long JM, Holtzman DM. Alzheimer disease: An update on pathobiology and treatment strategies. Cell 2019, 179: 312–339.

3. Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, et al. Alzheimer’s disease drug development pipeline: 2022. Alzheimers Dement (N Y) 2022, 8: e12295.

4. Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances. Mol Neurodegener 2020, 15: 30.

5. Sharma C, Kim S, Nam Y, Jung UJ, Kim SR. Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer’s disease. Int J Mol Sci 2021, 22: 4850.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of transcranial magnetic stimulation on cognitive function in post-stroke patients: a systematic review and meta-analysis;BMC Neurology;2024-07-05

2. Exploring Potential Mechanisms Accounting for Iron Accumulation in the Central Nervous System of Patients with Alzheimer’s Disease;Cells;2024-04-16

3. Neuroprotective effects of repetitive transcranial magnetic stimulation on Alzheimer's disease: Undetermined therapeutic protocols and mechanisms;Neuroprotection;2024-03